INTREPID FAMILY OFFICE LLC
Family OfficePosition in CCCC — C4 Therapeutics, Inc.
CIK 1596197
SARASOTA, FL
Position in CCCC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$303,550
+$145,750 QoQ
Shares Held
65,000
+8.3% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#79
of 147 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CCCC Over Time
Shares Held
Position Value (USD)
Derivatives in CCCC
reported options exposure · as of Dec 31, 2024CallValue
$36,000
CallShares
10,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026INTREPID FAMILY OFFICE LLC holds $303,550 across 1 Biotechnology name. CCCC ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CCCC |
C4 Therapeutics, Inc.
This page
|
65,000 | $303,550 |
All Filings in CCCC
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $303,550 | 65,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $157,800 | 60,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $105,050 | 55,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $155,400 | 70,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $57,200 | 40,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $64,000 | 40,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $144,000 | 40,000 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $36,000 | 10,000 | Call | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||